Advertisement

Agents and Actions

, Volume 1, Issue 2, pp 46–48 | Cite as

Are biogenic amines involved in the mechanism of action of the tetrahydrocannabinols?

  • Rose Dagirmanjian
  • Harold C. Hodge
Hypothesis

Keywords

Biogenic Amine Tetrahydrocannabinol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Mayor's Committee on Marihuana,The marihuana Problem in the City of New York. Sociological, Medical. Psychological, and Pharmacological Studies (Jacques Cattell Press, Lancaster, Pennsylvania 1944).Google Scholar
  2. [2]
    H. Isbell, C. W. Gorodetzsky, D. Jasinski, U. Claussen, F. v. Spulak andF. Korte,Effects of (−) β 9 -Trans-Tetrahydrocannabinol in Man, Psychopharmacologica11, 184–188 (1967).CrossRefGoogle Scholar
  3. [3]
    R. Adams, M. Harfenst andS. Loewe,New Analogs of Tetrahydrocannabinol XIX, J. Am. Chem. Soc.71, 1624–1628 (1949).CrossRefGoogle Scholar
  4. [4]
    Y. Gaoni andJ. Mechoulam,Hashish III. The Isolation, Structure Partial Synthesis of an Active Constituent of Hashish, J. Am. Chem. Soc.86, 1646 to 1647 (1964).Google Scholar
  5. [5]
    F. Korte, M. Haag andU. Claussen,Tetrahydrocannabinolcarboxylic Acid, a Component of Hashish, Angew. Chem. (Intern. Ed.)4, 872 (1965).CrossRefGoogle Scholar
  6. [6]
    E. C. Taylor, K. Lenard andY. Shvo,Active Constituents of Hashish. Synthesis of dl-β 6 -3, 4, Trans-Tetrahydrocannabinol, J. Am. Chem. Soc.88, 367–369 (1966).CrossRefGoogle Scholar
  7. [7]
    D. E. Fahrenholtz, M. Lurie andR. W. Kierstead The Total Synthesis of dl-β 9 -Tetrahydrocannabinol and of dl-β- 8 -Tetrahydrocannabinol Racemates of Active Constituents of Marihuana, J. Am. Chem. Soc.88, 2079–2080 (1966).CrossRefGoogle Scholar
  8. [8]
    Y. Gaoni andJ. Mechoulam,Hashish IX. Concerning the Isomerization of β 1 -to β 1 { 6 }-Tetrahydrocannabinol,88, 5673–5675 (1966).Google Scholar
  9. [9]
    S. Loewe,Studies on the Pharmacology and Acute Toxicity of Compounds with Marihuana Activity, J. Pharmac. exp. Ther.88, 1954–1961 (1946).Google Scholar
  10. [10]
    T. P. Davis andH. H. Ramsey,Antiepileptic Action of Marihuana Active Substances, Fedn Proc.8, 284–285 (1949).Google Scholar
  11. [11]
    S. Loewe andL. S. Goodman,Anticonvulsant Action of Marihuana-Like Substances, Fedn Proc.6, 352 (1947).Google Scholar
  12. [12]
    S. Loewe,Cannabiswirkstoffe und Pharmakologie der Kannabinole, Arch. exp. Path. Pharmak.211, 175–193 (1950).Google Scholar
  13. [13]
    R. Dagirmanjian andE. S. Boyd,Some Pharmacological Effects of Two Tetrahydrocannabinols, J. Pharmac. exp. Ther.135, 25–33 (1962).Google Scholar
  14. [14]
    C. A. M. Sampaio, A. J. Lapa andJ. R. Valle,Influence of Cannabis Tetrahydrocannabinol and Parahexylon the Linguomandibular Reflex of Dog, J. Pharm. Pharmac.19, 552–554 (1967).Google Scholar
  15. [15]
    S. Loewe,Synergism of Cannabis and Butyl-bromoallylbarbituric Acid, J. Am. Pharm. Ass. Sci. Ed.29, 162–163 (1940).Google Scholar
  16. [16]
    J. C. Garriott, L. J. King, R. B. Forney andF. W. Hughes,Effects of Some Tetrahydrocannabinols on Sleeping Time and Amphetamine Induced Hyperactivity in Mice, Life Sci.6, 2119–2128 (1967).CrossRefPubMedGoogle Scholar
  17. [17]
    E. S. Boyd, E. D. Hutchinson, L. C. Gardner andD. A. Meritt,Effects of Tetrahydrocannabinols and Other Drugs on Operant Behavior in Rats, Arch. Int. Pharmacodyn. Ther.144, 533–554 (1963).PubMedGoogle Scholar
  18. [18]
    E. S. Boyd andD. A. Meritt,Effects of Thiopental and a Tetrahydrocannabinol Derivative of Arousal and Recruiting in the Cat, J. Pharmac. exp. Ther.149, 138–145 (1965).Google Scholar
  19. [19]
    E. S. Boyd andD. A. Meritt,Effects of Barbiturates and a Tetrahydrocannabinol Derivative on Recovery Cycles of Medial Lemniscus, Thalamus and Reticular Formation in the Cat, J. Pharmac. exp. Ther.151, 376 to 384 (1966).Google Scholar
  20. [20]
    H. J. Bein,The Pharmacology of Rauwolfia, Pharmac. Rev.8, 435–483 (1956).Google Scholar
  21. [21]
    J. J. Lewis,Rauwolfia Alkaloids, J. Pharm. Pharmac.8, 465–494 (1956).Google Scholar
  22. [22]
    H. J. Bein,Zur Pharmakologie der Reserpine eines neuen Alkaloids aus Rauwolfia serpentina Benth., Experientia9, 107–110 (1953).Google Scholar
  23. [23]
    J. H. Trapold, A. J. Plummer andF. F. Yonkman,Cardiovascular and Respiratory Effects of Serpasil, a New Crystalline Alkaloid from Serpentina Benth. in the Dog, J. Pharmac. exp. Ther.110, 205–214 (1954).Google Scholar

Copyright information

© Birkhäuser Verlag 1969

Authors and Affiliations

  • Rose Dagirmanjian
    • 1
    • 2
  • Harold C. Hodge
    • 1
    • 2
  1. 1.Departments of PharmacologyOhio State University College of MedicineColumbus
  2. 2.School of Medicine and DentistryUniversity of RochesterRochester

Personalised recommendations